473 filings
Page 2 of 24
8-K
iva0ke
2 Oct 23
Departure of Directors or Certain Officers
4:45pm
8-K
d5c0afrafoaget7 8w
9 Aug 23
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
8shcxofe9jev 4mo
19 Jul 23
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
7:30am
8-K
2axv7 bc1ujrhclk595
6 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
DEFA14A
myat6wr8
22 May 23
Additional proxy soliciting materials
7:31am
8-K
c7qwzo8
22 May 23
Other Events
7:30am
8-K
wbolw
10 May 23
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
4:15pm
8-K
gbsxq 0n9rg6
2 May 23
ADMA Biologics Announces Amendment to Credit Agreement
9:07am
ARS
yzwyv r5eq
13 Apr 23
Annual report to shareholders
4:35pm
DEFA14A
bqfnvii2x3mkl1
13 Apr 23
Additional proxy soliciting materials
4:33pm
8-K
j37sfwl2k rnc49
23 Mar 23
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:15pm
8-K
xcpqc10mil pvx
10 Mar 23
Departure of Directors or Certain Officers
4:50pm
8-K
a94k5
8 Feb 23
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
7:22am
8-K
9grrg4qtz3n3gnx s2
17 Jan 23
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
8:30am
8-K
wdzg9s
9 Dec 22
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:30pm
424B5
v89ew6j1sirv3v inagz
7 Dec 22
Prospectus supplement for primary offering
4:43pm